Diabetes Mellitus(ISSN:2072-0351)

Diabetes Mellitus ( ISSN:2072-0351, E-ISSN:2072-0378) is a peer-reviewed scopus-indexed journal from 2012 to present. The publisher of this journal is Russian Association of Endocrinologists. Diabetes Mellitus committed to gathering and disseminating excellent research achievements. The journal welcomes all types of Medicine journal includes General Medicine, Internal Medicine, Endocrinology, Diabetes and Metabolism, Biochemistry, Genetics and Molecular Biology .

Scopus Indexed (2025) img

Diabetes Mellitus(ISSN:2072-0351)

Submission Date

(Vol 28 , Issue 01 ) | 06 Feb 2025

Day
Hour
Min
Sec

Valunteer

( Vol 27 , Issue 06 ) | 16 Aug 2025

Aim And Scopes

Diabetes Mellitus(ISSN:2072-0351)

Adult-onset diabetes, Congenital diabetes, Diabetic ketoacidosis, Diagnosis, Gestational diabetes, Insulin-dependent diabetes mellitus, Neuropathy and nephropathy, Pathogenesis, Renal failure and impotence, Clinical management, Coronary heart disease, Diabetic retinopathy, Gastrointestinal disorders, Hypertension and hyperlipidemia, Juvenile diabetes, Non insulin-dependent diabetes mellitus, Peripheral vascular disease,
Our Latest Journal
Diabetes Mellitus(ISSN:2072-0351)

DM-06-08-2025-7129

Diabetes Mellitus


Clinical characteristics of patients with different subtypes of gestational diabetes mellitus: research results

Gestational diabetes mellitus (GDM) is one of the most common diseases during pregnancy. To date, there is evidence showing that not all pregnant women with GDM have the same risks of developing complications. Identification of patients at increased risk of complications may be necessary given the increasing prevalence of GDM. The need for a more detailed study of GDM subtypes to identify patie

DM-06-08-2025-7128

Diabetes Mellitus


Analysis of the effectiveness of outpatient treatment of patients with diabetic foot

Diabetic foot syndrome is a late complication of diabetes mellitus and the main reason for non-traumatic amputations of the lower extremities in diabetic patients. Currently, standards of medical care have been developed and implemented for the treatment and prevention of this complication. At the same time, there is a lack of publications on the effectiveness of specialized care, especially at

DM-06-08-2025-7127

Diabetes Mellitus


The Effect of Glibenclamide on the Functional Activity of КATP Channels of Cerebral Arteries in Rats with Streptozotocin Diabetes Mellitus

In the treatment of diabetes mellitus (DM) for a persistent reduction in blood glucose levels it was widely used glibenclamide — a KATP channels blocker. However, its effects on cerebral circulation have been studied very little. A decrease in the functional activity of KATP channels due to their blocking by glibenclamide against the background of developed endothelial dysfunction may lea

DM-06-08-2025-7126

Diabetes Mellitus


Practical Applications of Russian DPP4 Inhibitor Gosogliptin in “Palitra” Large-Scale Observational Study

To date, the results of Metformin, Gosogliptin and combination thereof have not been studied on a large patient population with type 2 diabetes mellitus (DM2), including comorbid patients, in real clinical settings in the Russian Federation. The aim is to evaluate the efficacy, safety, treatment adherence and satisfaction of patients with DM2 with the use of Metformin and Gosogliptin sugar-lowe

DM-06-08-2025-7125

Diabetes Mellitus


Diabetes mellitus in the Russian Federation: dynamics of epidemiological indicators according to the Federal Register of Diabetes Mellitus for the period 2010–2022

The clinical and epidemiological characteristics of diabetes mellitus (DM) and the quality of its therapy are the key prognostic dominant that determines the organizational aspects of the diabetic service. The continuous dynamic monitoring of DM has been carried out in the Russian Federation (RF) since 1996 through the activities of the Federal Register of Diabetes Mellitus (FDR). The aim of ou

Diabetes Mellitus Logo